BioWorld MedTech

June 27, 2016

Resistant superbug s arrival highlights the need for more effective diagnostic products

Politicians and medical experts worldwide alike have decried the lack of innovation in antibiotics an area that has been neglected for three decades but another area is turning out to be just as important: diagnostics. Read More

Cut the blame game, infection control is a shared problem

What s inside your IV catheter?

Med-tech industry tries to find footing in wake of affirmative Brexit vote

FDA informs Franken MDRs offer no news on Medtronic s Infuse

South Korea cautiously considering 3-D printed medical instruments

Other news to note

Product briefs

MDD's Company Stock Report

Appointments and advancements

Neurology Extra

Rapid point-of-care tests for anti-microbial resistance

NIH changes set industry up for workforce, ideas drought

BioWorld

On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...

Today's news in brief

BioWorld

BioWorld briefs for March 10, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for March 10, 2025

Hummingbird migrates ADCs, tech to newco Callio’s $187M debut

BioWorld

Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...

Illustration of Magnet Biomedicine's Trueglue platform

Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology

BioWorld

About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...